Dharti Proteins Oct 13, 2026 board meet: bonus plan

What the company has scheduled

Dharti Proteins Ltd has scheduled a board meeting for Tuesday, October 13, 2026. The company described this as its fourth Board Meeting of FY27. The date also appears as the “Next Results Date” on the company’s event calendar. The board is expected to take up financial results and a proposal related to bonus shares. The announcement was filed with BSE Limited under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key agenda items: results and bonus issue

The main agenda item is consideration and approval of audited standalone financial results for the second quarter (Q2FY27) and the half-year (H1FY27) ended September 30, 2026. The agenda also includes taking on record the interim audit report. Alongside results, the board will consider a proposal for issuing bonus shares to public shareholders. The company has linked this proposal to compliance requirements on minimum public shareholding.

Why the bonus proposal is being considered

Dharti Proteins has stated that the bonus issue proposal is aimed at achieving compliance with Minimum Public Shareholding requirements. The filing cites Rule 19A of the Securities Contracts (Regulation) Rules, 1957, read with Regulation 38 of SEBI (LODR) Regulations, 2015. The stated purpose is to “rectify or maintain” the required minimum public shareholding level through a bonus issue to public shareholders. This framing makes the bonus proposal more compliance-driven than a routine capital reward announcement.

What is not disclosed yet

The preliminary notice does not disclose the bonus ratio. It also does not provide details on how the capital structure would change after the issue. Investors tracking the development will have to wait for the board’s decision and any subsequent detailed corporate announcement. The company also maintains a “Dharti Proteins Bonus” history page where dates such as announcement date, record date, ex-bonus date, and bonus ratio can be tracked when disclosed.

Recent stock and event context

The page shows an LTP of 66.92, up 4.99% at the time of the snapshot. The corporate calendar also flags October 13, 2026 for “Quarterly Results & Bonus issue,” aligning with the board agenda. Separately, the company noted that the trading window for equity shares was closed starting October 1, 2026. This restriction applies to Directors, Promoters, Designated Persons, and Specified Connected Persons. The trading window is stated to remain closed until 48 hours after the company declares its unaudited financial results for the quarter and half-year ending September 30, 2026.

Snapshot of available financial data

From the data shown, Dharti Proteins reported that its net profit fell by -180% versus the same period last year to ₹0.14 crore in Q1 2026-27. On a quarterly growth basis, it reported a 69.57% jump in net profit versus the previous three months. Revenue is shown as ₹0.00 crore as on June 2026 (Q1 FY27). These numbers are presented as-is in the source snapshot and provide the immediate backdrop ahead of the Q2 and half-year audited results.

AGM developments that set the stage

Dharti Proteins said it passed all 13 resolutions at its 32nd Annual General Meeting held on September 28, 2026. The outcome, disclosed to BSE, stated that public shareholders cast zero votes across all agenda points, while promoters voted on related-party items. The scrutinizer’s report confirmed that all resolutions were duly approved with the requisite majority. The company also disclosed that it has a six-member board with four independent directors, and that no dividend was proposed due to losses.

Board and governance changes approved at the AGM

At the AGM, three individuals were proposed for appointment as Non-Executive Independent Directors: Ms. Shubhangi Janifer, Ms. Poorva Jain, and Mrs. Chitra Naraniwal. Additionally, Mr. Karnik Shasankan Pillai was proposed for appointment as a Non-Executive Director. The existing Chairman and Managing Director, Mr. Jatinbhai Ramanbhai Patel, retired by rotation and offered himself for re-appointment. The board also approved appointment of M/s Dharti Patel & Associates as Secretarial Auditors for a five-year term spanning FY26 to FY30.

Capital and funding resolutions highlighted

The AGM notes also referenced broader corporate actions, including enhancement of borrowing limits up to ₹5,000 crore under Section 180(1)(c). It also included approval of an unsecured loan of up to ₹100 crore from a director, with a conversion option. The company disclosed that it is emerging from a Corporate Insolvency Resolution Process (CIRP) approved by NCLT on November 18, 2025, under which share capital was restructured, liabilities extinguished, and fresh capital infused.

Other regulatory and exchange updates in early October

The snapshot includes additional corporate filings around the same period. It states that ROC approved an object clause alteration on October 6, 2026, following the September 28, 2026 AGM special resolution. It also notes an intimation regarding trading approval received from BSE Limited for 5,00,000 equity shares of face value ₹10 each. Another line states BSE approved trading of 5 lakh shares from October 8, 2026, after resolution plan restructuring.

What to watch on October 13

The October 13 board meeting is positioned around two decision points: audited standalone financial results for Q2FY27 and H1FY27, and the bonus share proposal tied to minimum public shareholding compliance. While the company has not shared the bonus ratio in the preliminary intimation, it has clearly linked the proposal to Rule 19A and SEBI LODR requirements. The next concrete update should come through the board outcome disclosure after the meeting.

Key facts table